Clorox Company Investment Analysis - January 2026

As we move into the new year, investors are keenly analyzing the financial landscape to make informed decisions. This monthly stock report provides a comprehensive overview of The Clorox Company (NYSE: CLX), examining its position within the household and personal products industry, its recent stock performance, financial metrics, news developments, and market sentiment.

Company Overview

Founded in 1913 and headquartered in Oakland, California, The Clorox Company operates within the Household & Personal Products industry of the Consumer Defensive sector. Clorox has established itself as a well-recognized name in consumer products, manufacturing and marketing a diverse range of items, including cleaning and disinfecting products, cat litter, grilling essentials, water-filtration systems, natural personal care items, and various food products. The company segments its offerings into four main areas: Health and Wellness, Household, Lifestyle, and International.

With total revenue approximating $6.77 billion, Clorox demonstrates a solid foundation and presence in a competitive market. Currently, analysts recommend a cautious stance on shares, suggesting investors consider a 'hold' due to the complex dynamics influencing stock performance.

52-Week Price Performance Analysis

52-Week Price Performance Chart

The Clorox Company's stock has faced significant challenges in recent months, with a marked bearish trend highlighted by a 35.36% decline from its 52-week high of $164.22 to a low of $96.66. As of January 1, 2026, CLX is trading at $101.55, markedly below the previous year's peak.

Technical Insights

The 52-week stock price chart displays a consistent pattern of lower highs and lower lows, with ongoing selling pressure evident throughout the year. Key support appears strong around the $100 psychological level, while resistance looms near the $160 mark. The stock's current price is sitting just below the 50-day moving average of $105.698, which serves as a dynamic resistance level, complicating recovery efforts.

The price action suggests a potential stabilization near the $100 support, yet there is a lack of strong bullish reversal signals or breakout patterns. Investors should monitor this area carefully, as substantial movement above resistance levels is required to shift the bearish sentiment currently dominating the stock.

Financial Performance and Metrics

The financial health of Clorox reflects a company that has shown resilience in challenging market conditions. As stated, total revenue recently reached approximately $6.77 billion, while Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) stands at $1.22 billion. These figures indicate a steady operational performance, appealing to value-focused investors.

Key Financial Metrics:

• Market Price: $101.55
• Outstanding Shares: 121,980,379
• Short Interest: 6.64% of the float (approximately 7,039,475 shares)
• Quarterly Dividend: Increased to $1.24, the 48th consecutive year of growth
• Dividend Yield: Approximately 4%
• Mean Price Target: $122.41, with a high of $163.00 and a low of $103.00

Despite the setback in share price, the company's commitment to dividend growth underscores its dedication to delivering shareholder value, even as the market environment fluctuates.

Recent News and Developments

In recent months, Clorox has faced both positive and negative developments: - Dividend Increase: In July 2025, Clorox upped its quarterly dividend from $1.22 to $1.24, marking 48 consecutive years of dividend growth, which might be appealing to income-focused investors (Clorox Investor Relations).

• Earnings Miss: Fiscal third-quarter earnings released in May 2025 highlighted a disappointing performance, with earnings of $1.45 per share on sales of $1.67 billion, falling short of analyst expectations (The Motley Fool).

• Analyst Downgrades: In June 2025, Jefferies adjusted its price target for Clorox from $167 to $145 due to concerns surrounding the company's Enterprise Resource Planning (ERP) rollout, which may affect operational performance and leverage (Investing.com).

These developments reflect the underlying challenges and the potential for recovery in Clorox's operational performance.

Market Sentiment and Analyst Recommendations

The market sentiment surrounding Clorox has been cautious, with a consensus recommendation classified as a 'hold.' The mean recommendation score is approximately 3.11 from a total of 17 analysts, indicating a relatively stable outlook despite recent stock performance challenges.

Analyst Consensus:

• Mean Target Price: $122.41
• High Price Target: $163.00
• Low Price Target: $103.00
• Resistance Level: $160
• Support Level: $100

The stock's position at $101.55 illustrates substantial potential upside; however, it is essential to monitor both market conditions and Clorox's performance against established key levels. Investors should approach the stock with caution, particularly given the bearish momentum exhibited in recent months.

Conclusion

The Clorox Company represents a well-known entity within the consumer goods sector, with a rich history and robust commitment to shareholder returns through dividend growth. However, current market conditions and recent performance challenges necessitate a measured investment approach. With a stable financial foundation and a cautious analyst outlook, potential investors may find value in Clorox amid market volatility. The company's efforts to stabilize near its support level could offer insight into its future price trajectory, making it essential for investors to stay informed and responsive to emerging developments.